Literature DB >> 28176225

Regulation of normal and leukemic stem cells through cytokine signaling and the microenvironment.

Virginia Camacho1, Victoria McClearn1, Sweta Patel1, Robert S Welner2,3.   

Abstract

Leukemias depend on transformed stem cells for their growth and thus these cells represent important therapeutic targets. However, leukemic stem cells resemble normal hematopoietic stem cells (HSCs) with respect to most surface markers, gene expression patterns, and ability to be transplanted. Furthermore, the microenvironment that supports healthy HSCs non-hematopoietic populations, and immune cells correspondingly, the cytokines, adhesion molecules and signal transduction pathways are also impaired during leukemogenesis. This altered environment promotes leukemic growth specifically through pro-inflammatory cytokines. Here, we characterize normal and leukemic signaling, as well as the instructive cues from the neighboring hematopoietic cells and the microenvironment that promote stem cell self-renewal and differentiation.

Entities:  

Keywords:  HSC; Leukemia; Microenvironment; Niche

Mesh:

Substances:

Year:  2017        PMID: 28176225     DOI: 10.1007/s12185-017-2184-6

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  93 in total

1.  Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues.

Authors:  Steffen Massberg; Patrick Schaerli; Irina Knezevic-Maramica; Maria Köllnberger; Noah Tubo; E Ashley Moseman; Ines V Huff; Tobias Junt; Amy J Wagers; Irina B Mazo; Ulrich H von Andrian
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

2.  Recurrent expression signatures of cytokines and chemokines are present and are independently prognostic in acute myelogenous leukemia and myelodysplasia.

Authors:  Steven M Kornblau; David McCue; Neera Singh; Wenjing Chen; Zeev Estrov; Kevin R Coombes
Journal:  Blood       Date:  2010-08-02       Impact factor: 22.113

3.  In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche.

Authors:  Joji Fujisaki; Juwell Wu; Alicia L Carlson; Lev Silberstein; Prabhakar Putheti; Rafael Larocca; Wenda Gao; Toshiki I Saito; Cristina Lo Celso; Hitoshi Tsuyuzaki; Tatsuyuki Sato; Daniel Côté; Megan Sykes; Terry B Strom; David T Scadden; Charles P Lin
Journal:  Nature       Date:  2011-06-08       Impact factor: 49.962

4.  Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironment.

Authors:  Lei Dong; Wen-Mei Yu; Hong Zheng; Mignon L Loh; Silvia T Bunting; Melinda Pauly; Gang Huang; Muxiang Zhou; Hal E Broxmeyer; David T Scadden; Cheng-Kui Qu
Journal:  Nature       Date:  2016-10-26       Impact factor: 49.962

5.  JAK-STAT pathway activation in malignant and nonmalignant cells contributes to MPN pathogenesis and therapeutic response.

Authors:  Maria Kleppe; Minsuk Kwak; Priya Koppikar; Markus Riester; Matthew Keller; Lennart Bastian; Todd Hricik; Neha Bhagwat; Anna Sophia McKenney; Efthymia Papalexi; Omar Abdel-Wahab; Raajit Rampal; Sachie Marubayashi; Jonathan J Chen; Vincent Romanet; Jordan S Fridman; Jacqueline Bromberg; Julie Teruya-Feldstein; Masato Murakami; Thomas Radimerski; Franziska Michor; Rong Fan; Ross L Levine
Journal:  Cancer Discov       Date:  2015-01-08       Impact factor: 39.397

6.  The IL-2/CD25 axis maintains distinct subsets of chronic myeloid leukemia-initiating cells.

Authors:  Chiharu I Kobayashi; Keiyo Takubo; Hiroshi Kobayashi; Ayako Nakamura-Ishizu; Hiroaki Honda; Keisuke Kataoka; Keiki Kumano; Hideo Akiyama; Tetsuo Sudo; Mineo Kurokawa; Toshio Suda
Journal:  Blood       Date:  2014-02-26       Impact factor: 22.113

7.  GATA Factor-Dependent Positive-Feedback Circuit in Acute Myeloid Leukemia Cells.

Authors:  Koichi R Katsumura; Irene M Ong; Andrew W DeVilbiss; Rajendran Sanalkumar; Emery H Bresnick
Journal:  Cell Rep       Date:  2016-08-18       Impact factor: 9.423

Review 8.  The senescence-associated secretory phenotype: the dark side of tumor suppression.

Authors:  Jean-Philippe Coppé; Pierre-Yves Desprez; Ana Krtolica; Judith Campisi
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

9.  An alternate pathway for T cell development supported by the bone marrow microenvironment: recapitulation of thymic maturation.

Authors:  M E García-Ojeda; S Dejbakhsh-Jones; I L Weissman; S Strober
Journal:  J Exp Med       Date:  1998-06-01       Impact factor: 14.307

10.  Senescence-associated secretory phenotype favors the emergence of cancer stem-like cells.

Authors:  J Cahu; S Bustany; B Sola
Journal:  Cell Death Dis       Date:  2012-12-20       Impact factor: 8.469

View more
  12 in total

Review 1.  Metabolic underpinnings of leukemia pathology and treatment.

Authors:  Travis Nemkov; Angelo D'Alessandro; Julie A Reisz
Journal:  Cancer Rep (Hoboken)       Date:  2018-10-07

2.  Isolation of Swine Bone Marrow Lin-/CD45-/CD133 + Cells and Cardio-protective Effects of its Exosomes.

Authors:  Hongxiao Li; Jianjun Gu; Xiaolin Sun; Qisheng Zuo; Bichun Li; Xiang Gu
Journal:  Stem Cell Rev Rep       Date:  2022-08-04       Impact factor: 6.692

3.  Splenic red pulp macrophages provide a niche for CML stem cells and induce therapy resistance.

Authors:  Elias D Bührer; Michael A Amrein; Stefan Forster; Stephan Isringhausen; Christian M Schürch; Salil S Bhate; Tess Brodie; Joel Zindel; Deborah Stroka; Mohamad Al Sayed; César Nombela-Arrieta; Ramin Radpour; Carsten Riether; Adrian F Ochsenbein
Journal:  Leukemia       Date:  2022-09-26       Impact factor: 12.883

Review 4.  One Stone, Two Birds: N6-Methyladenosine RNA Modification in Leukemia Stem Cells and the Tumor Immune Microenvironment in Acute Myeloid Leukemia.

Authors:  Xianfeng Ouyang; Yuping Gong
Journal:  Front Immunol       Date:  2022-06-02       Impact factor: 8.786

5.  Loss of interleukin-10 activates innate immunity to eradicate adult T-cell leukemia-initiating cells.

Authors:  Hiba El Hajj; Rita Hleihel; Marwan El Sabban; Julie Bruneau; Ghazi Zaatari; Morgane Cheminant; Ambroise Marçais; Abdou Akkouche; Hideki Hasegawa; William Hall; Hugues De Thé; Olivier Hermine; Ali Bazarbachi
Journal:  Haematologica       Date:  2021-05-01       Impact factor: 9.941

Review 6.  A Role for the Bone Marrow Microenvironment in Drug Resistance of Acute Myeloid Leukemia.

Authors:  Seyed Mohammadreza Bolandi; Mahdi Pakjoo; Peyman Beigi; Mohammad Kiani; Ali Allahgholipour; Negar Goudarzi; Jamshid S Khorashad; Anna M Eiring
Journal:  Cells       Date:  2021-10-21       Impact factor: 6.600

Review 7.  Concise Review: Chronic Myeloid Leukemia: Stem Cell Niche and Response to Pharmacologic Treatment.

Authors:  Elena Arrigoni; Marzia Del Re; Sara Galimberti; Giuliana Restante; Eleonora Rofi; Stefania Crucitta; Claudia Baratè; Mario Petrini; Romano Danesi; Antonello Di Paolo
Journal:  Stem Cells Transl Med       Date:  2018-02-08       Impact factor: 6.940

8.  TLR engagement induces ARID3a in human blood hematopoietic progenitors and modulates IFNα production.

Authors:  Michelle L Ratliff; Malini Shankar; Joel M Guthridge; Judith A James; Carol F Webb
Journal:  Cell Immunol       Date:  2020-09-09       Impact factor: 4.868

9.  Bone marrow Tregs mediate stromal cell function and support hematopoiesis via IL-10.

Authors:  Virginia Camacho; Victoria R Matkins; Sweta B Patel; Jeremie M Lever; Zhengqin Yang; Li Ying; Ashley E Landuyt; Emma C Dean; James F George; Henry Yang; Paul Brent Ferrell; Craig L Maynard; Casey T Weaver; Heth R Turnquist; Robert S Welner
Journal:  JCI Insight       Date:  2020-11-19

10.  ANP32B-mediated repression of p53 contributes to maintenance of normal and CML stem cells.

Authors:  Shuo Yang; Xiao-Na Zhu; Hui-Lin Zhang; Qian Yang; Yu-Sheng Wei; Di Zhu; Meng-Di Liu; Shao-Ming Shen; Li Xia; Ping He; Meng-Kai Ge; Yi-Lian Pan; Meng Zhao; Ying-Li Wu; Jun-Ke Zheng; Guo-Qiang Chen; Yun Yu
Journal:  Blood       Date:  2021-12-16       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.